Available On Demand
Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.
This session will explore how HTA agencies are beginning to include health equity in their access recommendations and discuss the practical impact of this trend. Our experts will share insights from Trinity Life Sciences’ Value Center of Excellence on incorporating the work of health equity teams into access materials in a way that moves the needle for payers.
Key Webinar Topics
- The prevalence of health equity considerations in HTA outcomes
- Practical steps to incorporate health equity into access materials
- The importance of health equity compared to other factors
- Emerging value drivers in the industry
Complete the form below to view the on-demand webinar:
By clicking "I agree" above, you are agreeing that Trinity will use and protect your personal data in accordance with our Privacy Policy. You can opt out of future marketing communications at any time by clicking the unsubscribe link at the bottom of any marketing email you receive from Trinity.